Provided by Tiger Trade Technology Pte. Ltd.

MSA Safety

178.70
-1.1200-0.62%
Pre-market: 178.700.00000.00%04:00 EDT
Volume:233.01K
Turnover:41.79M
Market Cap:6.89B
PE:22.22
High:181.76
Open:181.76
Low:178.10
Close:179.82
52wk High:208.92
52wk Low:151.11
Shares:38.58M
Float Shares:36.18M
Volume Ratio:1.21
T/O Rate:0.64%
Dividend:2.13
Dividend Rate:1.19%
EPS(TTM):8.04
EPS(LYR):7.09
ROE:23.66%
ROA:11.07%
PB:4.93
PE(LYR):25.20

Loading ...

MSA Safety Announces 56 Consecutive Years of Annual Dividend Increases

THOMSON REUTERS
·
May 04

Alterity Therapeutics Releases Appendix 4C – Q3 FY26 Quarterly Cash Flow Report & Corporate Update

GlobeNewswire
·
Apr 30

Press Release: OBOOK Holdings Inc. Announces Financial Results for the Full Year 2025 Ended December 31, 2025

Dow Jones
·
Apr 30

Earning Preview: MSA Safety this quarter’s revenue is expected to increase by 12.09%, and institutional views are bullish

Earnings Agent
·
Apr 27

Plus Therapeutics Initiates Manufacturing Activities with SpectronRx Under a Master Services Agreement to Support GMP Pivotal Trial Readiness for REYOBIQ™

GlobeNewswire
·
Apr 23

Alterity Therapeutics Presents New Analysis of ATH434 Phase 2 Trial Data in Late Breaking Science Session of the American Academy of Neurology

GlobeNewswire
·
Apr 22

Alterity’s ATH434 Shows Phase 2 Efficacy Signal in MSA on New Composite Scale

TIPRANKS
·
Apr 22

MSA Safety showcases G1 XR SCBA at FDIC International

Reuters
·
Apr 21

MSA Safety schedules first-quarter earnings conference call

Reuters
·
Apr 21

Press Release: Mineros S.A. Updates Market on Special Meeting of Shareholders Scheduled for April 30, 2026, and Confirms Successful Closing of Previously Announced Transaction

Dow Jones
·
Apr 17

Alterity to Spotlight ATH434 MSA Data in Late-Breaker at AAN Meeting

TIPRANKS
·
Apr 16

Alterity Therapeutics to Host Virtual KOL Event to Share New Insights on ATH434 for the Treatment of Multiple System Atrophy

GlobeNewswire
·
Apr 15

Alterity Therapeutics Showcases ATH434 Progress in Virtual MSA KOL Event

TIPRANKS
·
Apr 15

SST001, an α-syn PET tracer from Mabwell's incubated company SynuSight Biotech, received NMPA approval to initiate a clinical trial

prnewswire
·
Apr 15

Tiziana Life Sciences Announces Late Breaking Poster Accepted for Presentation at the 7th World Parkinson Congress

GlobeNewswire
·
Apr 14

A Look At MSA Safety (MSA) Valuation After Recent Share Price Weakness

Simply Wall St.
·
Apr 02

MSA Safety Coverage Assumed by Jefferies at Hold

Dow Jones
·
Apr 01

MSA Safety assumed with a Hold at Jefferies

TIPRANKS
·
Mar 31

U.S. RESEARCH ROUNDUP-Dutch Bros, Phreesia, Starbucks

Reuters
·
Mar 31

MSA Safety Is Maintained at Neutral by Baird

Dow Jones
·
Mar 30